The Difference Between US and European VC Term Sheets

A venture capital term sheet can look deceptively simple. It may be only a few pages long and summarize the valuation, investment amount, investor rights, board structure, and other major conditions of a funding round. But those few pages can determine who controls important company decisions, how much founders ultimately own, and who gets paid first if the company is sold.

The basic concepts are similar on both sides of the Atlantic. US and European investors care about valuation, liquidation preferences, dilution, governance, founder commitments, and future financing. The difference is in how those terms are documented and implemented.

There is also no single “European term sheet.” A UK startup operates under a different legal framework from one incorporated in Germany, France, the Netherlands, or Estonia. Still, comparing the US model with common European practices reveals several important differences founders should understand.

The US model is unusually standardized

American venture financing has benefited from decades of standardization.

The National Venture Capital Association maintains widely used model legal documents covering everything from stock purchase agreements to investor rights and voting agreements. The documents are intended to reduce transaction costs, establish common industry norms, and provide consistent starting points for negotiations.

That means an experienced Silicon Valley founder, investor, or startup lawyer will recognize much of the structure of a conventional venture round.

The company is often a Delaware corporation, investors generally receive preferred stock, and founders and employees usually hold common stock or options. The term sheet establishes the major economic and governance terms, and detailed legal documents implement them after negotiations.

This standardization does not eliminate negotiation. It simply means both sides often begin from a familiar framework.

Europe has increasingly developed standardized documents too. In the UK, for example, the British Private Equity and Venture Capital Association has model venture documents, which were revised again in 2025.

But across Europe as a whole, differences in national company and tax law prevent the market from being quite as uniform.

Valuation works broadly the same way

The fundamental valuation mathematics does not change when a startup crosses the Atlantic.

Suppose investors put €2 million into a company at an €8 million pre-money valuation. The simplified post-money valuation becomes €10 million, giving the new investors 20% of the company.

American investors use the same calculation with dollars.

But founders should pay attention to what is included in that valuation. One important issue is the employee option pool.

An investor might require the startup to expand its employee option pool before the financing closes. If that increase occurs in the pre-money capitalization, the dilution effectively falls more heavily on existing shareholders rather than the new investor.

A headline valuation can therefore sound excellent while producing a less attractive ownership outcome.

The cap table after the transaction matters more than the number founders announce publicly.

Liquidation preferences can matter more than valuation

One of the most important terms in any venture deal is the liquidation preference.

Investors usually receive preferred shares with certain economic rights that ordinary shareholders do not have. A 1x liquidation preference generally means investors can recover their original investment before common shareholders receive proceeds in a qualifying exit. The US venture market commonly uses preferred stock with liquidation rights, and NVCA materials describe liquidation preference as giving investors priority over common shareholders in an exit.

Imagine investors put €5 million into a company that later sells for only €6 million. Who receives what can depend heavily on the liquidation terms.

Founders should pay particular attention to whether the preference is participating or non-participating and whether the multiple is 1x or something more aggressive.

These concepts appear in European venture deals too. The UK’s updated model documents, for example, specifically address how liquidation preferences operate.

The important lesson is universal: a €20 million valuation with harsh liquidation terms can ultimately be worse for founders than a somewhat lower valuation with cleaner economics.

Governance can look different across jurisdictions

VC investors are not only buying economic ownership. They frequently negotiate influence over important company decisions.

A term sheet might give an investor the right to appoint a board member or require investor approval before the company can take certain actions.

These reserved or protective matters could include issuing new shares, selling the company, changing the company’s constitutional documents, taking on significant debt, or completing other major transactions.

US venture deals frequently implement these protections through preferred-stock rights, voting agreements, board representation, and related contractual arrangements. NVCA’s current standard financing package includes separate investors’ rights, voting, and right-of-first-refusal and co-sale agreements.

European deals can achieve similar outcomes, but the legal mechanism depends on the company’s jurisdiction and corporate form.

This is one reason founders should avoid copying an American term sheet from the internet and assuming it can simply be used for a European company.

Founder vesting and leaver provisions deserve special attention

Investors want to know that the people they are backing will remain committed to the company.

Founder vesting is one solution. Instead of founders permanently owning all their shares from day one without conditions, some ownership effectively becomes tied to continued involvement.

US founders are familiar with arrangements such as four-year vesting with a one-year cliff.

European agreements can address the same risk through vesting and through “good leaver” and “bad leaver” provisions. These determine what happens to a founder’s shares if that person leaves the business under different circumstances. The UK’s 2025 model-document revisions, for example, included updates to bad-leaver provisions.

The details matter enormously.

A founder leaving because of serious misconduct is very different from someone becoming ill or being removed without cause. A badly drafted leaver clause can create substantial consequences for someone who has already spent years building the company.

Anti-dilution protection matters when things go wrong

Another term founders sometimes overlook is anti-dilution protection.

Suppose an investor buys shares at €10 each. Two years later, the startup struggles and has to raise another round at €5 per share.

That is a down round.

Anti-dilution provisions can adjust the earlier investor’s economic position to compensate for the lower financing price. Different formulas produce different consequences, and more aggressive protection can create significant additional dilution for founders and employees.

This is not merely theoretical. NVCA reported that 15.9% of US VC deals in 2025 were down rounds, the highest proportion in a decade.

Founders understandably focus on what happens if everything goes well. Term sheets are partly designed to establish what happens when it does not.

European deals have more jurisdiction-specific complexity

Perhaps the biggest practical difference is that “US venture capital” often means operating within a highly developed Delaware-centered framework, while European venture capital spans numerous legal systems.

A French SAS, German GmbH, Dutch BV, and UK private limited company are not interchangeable structures.

Tax treatment can differ. Employee option schemes can differ. Shareholder approvals can differ. Corporate governance rules can differ. Even terminology can change.

This makes local legal advice particularly important for European founders raising institutional capital.

The underlying negotiation may still sound familiar—valuation, ownership, liquidation, control, dilution—but the contracts implementing those decisions have to work under local law.

The most important terms are not always the headline terms

Founders naturally focus on valuation because it is easy to understand and easy to announce.

But a term sheet should be evaluated as a complete package.

A slightly higher valuation may come with stronger investor control, a larger pre-money option pool, aggressive liquidation preferences, restrictive founder provisions, or unfavorable anti-dilution protection.

Conversely, accepting a slightly lower valuation from an investor offering cleaner terms and a strong working relationship may sometimes leave founders in a better position.

That principle applies whether the startup is raising in San Francisco, London, Paris, Berlin, or Stockholm.

The biggest difference between US and European term sheets is ultimately not that they pursue completely different objectives. Investors on both sides want economic protection, governance rights, and a path to a return.

The difference is that the US has developed a particularly standardized legal playbook, while Europe still translates that playbook through multiple national legal systems.

For founders, the rule is simple: negotiate the entire deal, not just the valuation. The terms that look boring when the company is doing well can become the most important ones when circumstances change.